We have cloned Gb(3) synthase, the key alpha1, 4-galactosyltransferase in globo-series glycosphingolipid (GSL) synthesis, via a phenotypic screen, which previously yielded iGb(3) synthase, the alpha1,3-galactosyltransferase required in isoglobo-series GSL (Keusch, J. J., Manzella, S. M., Nyame, K. A., Cummings, R. D., and Baenziger, J. U. (2000) J. Biol. Chem. 33). Both transferases act on lactosylceramide, Galbeta1,4Glcbeta1Cer (LacCer), to produce Gb(3) (Galalpha1,4LacCer) or iGb(3) (Galalpha1, 3LacCer), respectively. GalNAc can be added sequentially to either Gb(3) or iGb(3) yielding globoside and Forssman from Gb(3), and isogloboside and isoForssman from iGb(3). Gb(3) synthase is not homologous to iGb(3) synthase but shows 43% identity to a human alpha1,4GlcNAc transferase that transfers a UDP-sugar in an alpha1, 4-linkage to a beta-linked Gal found in mucin. Extensive homology (35% identity) is also present between Gb(3) synthase and genes in Drosophila melanogaster and Arabidopsis thaliana, supporting conserved expression of an alpha1,4-glycosyltransferase, possibly Gb(3) synthase, throughout evolution. The isolated Gb(3) synthase cDNA encodes a type II transmembrane glycosyltransferase of 360 amino acids. The highest tissue expression of Gb(3) synthase RNA is found in the kidney, mesenteric lymph node, spleen, and brain. Gb(3) glycolipid, also called P(k) antigen or CD77, is a known receptor for verotoxins. CHO cells that do not express Gb(3) and are resistant to verotoxin become susceptible to the toxin following transfection with Gb(3) synthase cDNA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1074/jbc.M002630200 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Human Gb3/CD77 synthase: a glycosyltransferase at the crossroads of immunohematology, toxicology, and cancer research.
Cell Mol Biol Lett
November 2024
Laboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114, Wroclaw, Poland.
Article Synopsis
- Human Gb3/CD77 synthase, an enzyme, creates Galα1→4Gal structures on glycosphingolipids and glycoproteins, which are important for bacterial recognition in infections.
- The major product, Globotriaosylceramide (Gb3), acts as a receptor for harmful toxins from certain bacteria and is also linked to symptoms of Anderson-Fabry disease due to enzyme deficiency.
- Additionally, the synthase is implicated in cancer biology, playing a role in cancer cell survival and resistance to treatments, and influencing the P1PK blood group system.
CRISPR/Cas9-mediated suppression of A4GALT rescues endothelial cell dysfunction in a fabry disease vasculopathy model derived from human induced pluripotent stem cells.
Atherosclerosis
October 2024
Transplantation Research Center, College of Medicine, The Catholic University of Korea, Seoul, South Korea; Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The College of Medicine, The Catholic University of Korea, South Korea. Electronic address:
Background And Aims: The objective of this study was to investigate the efficacy of CRISPR/Cas9-mediated A4GALT suppression in rescuing endothelial dysfunction in Fabry disease (FD) endothelial cells (FD-ECs) derived from human induced pluripotent stem cells (hiPSCs).
Methods: We differentiated hiPSCs (WT (wild-type), WTC-11), GLA-mutant hiPSCs (GLA-KO, CMC-Fb-002), and CRISPR/Cas9-mediated A4GALT-KO hiPSCs (GLA/A4GALT-KO, Fb-002-A4GALT-KO) into ECs and compared FD phenotypes and endothelial dysfunction. We also analyzed the effect of A4GALT suppression on reactive oxygen species (ROS) formation and transcriptome profiles through RNA sequencing.
Delving into human α1,4-galactosyltransferase acceptor specificity: The role of enzyme dimerization.
Biochem Biophys Res Commun
December 2024
Biological and Chemical Research Center, Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093, Warsaw, Poland.
Human α1,4-galactosyltransferase (A4galt), a Golgi apparatus-resident GT, synthesizes Gb3 glycosphingolipid (GSL) and P1 glycotope on glycoproteins (GPs), which are receptors for Shiga toxin types 1 and 2. Despite the significant role of A4galt in glycosylation processes, the molecular mechanisms underlying its varied acceptor specificities remain poorly understood. Here, we attempted to elucidate A4galt specificity towards GSLs and GPs by exploring its interaction with GTs with various acceptor specificities, GP-specific β1,4-galactosyltransferase 1 (B4galt1) and GSL-specific β1,4-galactosyltransferase isoenzymes 5 and 6 (B4galt5 and B4galt6).
View Article and Find Full Text PDFCardiac manifestations of Fabry disease in G3Stg/GlaKO and GlaKO mouse models-Translation to Fabry disease patients.
PLoS One
May 2024
Rare Diseases Drug Discovery Unit, Takeda Development Center Americas Inc., Cambridge, Massachusetts, United States of America.
Article Synopsis
- Fabry disease (FD) is a genetic disorder caused by mutations in the GLA gene, leading to the accumulation of harmful substances in cells and resulting in various health issues, including pain and severe complications in organs like the heart and kidneys.
- Current treatments can help preserve kidney function but are less effective for heart problems, highlighting the need for better research models to test new drug therapies.
- Two mouse models (GlaKO and G3Stg/GlaKO) have been developed to study FD, with the latter demonstrating more severe tissue and cardiac issues, and research aims to evaluate cardiac health using advanced imaging techniques.
Effects of Histidine Oligomers in Lipid Nanoparticles on siRNA Delivery.
Macromol Biosci
August 2024
Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea.
In this study, histidine oligomer (oHis; 10mer)-incorporating LNPs (H10LNPs) are developed as a novel carrier for efficient siRNA delivery. Notably, the unmodified oHis (10mer) is greatly incorporated within LNPs through ionic interaction with siRNAs, which serves as an endosome escape enhancer. H10LNPs with a size of ≈65 nm demonstrate a significantly enhanced extent of endosomal escape, as evidenced by calcein assay and confocal microscopy images of intracellular fluorescence, surpassing conventional LNPs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!